Skip to content

Released Mar 12, 2018, before the open

10-K filed Mar 12, 2018, 71 days after period end · 0001144204-18-013981

Q4 2017 · 10-K
Revenue$0.00derivedno prior Q4 2016 on fileno prior Q3 2017 on file
Net Income-$5.33MN/M vs Q4 2016N/M vs Q3 2017
EPS Diluted-$0.25N/M vs Q4 2016N/M vs Q3 2017
Operating Income-$5,402,384N/M
Operating Cash Flowderived-$4,296,952N/M
Free Cash Flowderived-$4,296,952N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2017Q4 2016Q4 2015Q4 2014derived from reported figures
Revenue$0.00———
Net Income-$5.33M-$2.97M-$4.63M-$4.04M
EPS Diluted-$0.25-$0.16-$0.25—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR